HealthInvest Partners AB - Q1 2014 holdings

$140 Million is the total value of HealthInvest Partners AB's 18 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 55.6% .

 Value Shares↓ Weighting
CRL SellCharles Riv Labs Intl Inc$12,974,000
+11.7%
215,013
-1.8%
9.25%
-19.9%
AIQ BuyAlliance HealthCare Srvcs In$12,482,000
+79.1%
372,276
+32.1%
8.90%
+28.3%
HOLX BuyHologic Inc$11,974,000
+75.7%
556,920
+82.6%
8.53%
+25.8%
MDT SellMedtronic Inc$11,582,000
+2.0%
188,200
-4.9%
8.25%
-26.9%
V107SC BuyWellPoint Inc$11,329,000
+62.4%
113,800
+50.7%
8.07%
+16.4%
HRC BuyHill Rom Hldgs Inc$8,564,000
+27.7%
222,200
+37.0%
6.10%
-8.5%
LPNT BuyLifePoint Hospitals Inc$8,548,000
+22.8%
156,700
+19.0%
6.09%
-12.0%
CFN NewCareFusion Corp$8,430,000209,600
+100.0%
6.01%
MGLN NewMagellan Health Svcs Inc$8,331,000140,375
+100.0%
5.94%
AET NewAetna Inc New$8,314,000110,900
+100.0%
5.92%
CAH NewCardinal Health Inc$8,307,000118,700
+100.0%
5.92%
ESRX SellExpress Scripts Hldg Co$8,072,000
-31.8%
107,500
-36.2%
5.75%
-51.2%
GTS NewTriple-S Mgmt Corpcl b$5,724,000354,675
+100.0%
4.08%
THOR BuyThoratec Corp$5,492,000
+52.9%
153,366
+56.3%
3.91%
+9.5%
SKH BuySkilled Healthcare Group Inccl a$4,824,000
+30.6%
915,365
+19.2%
3.44%
-6.4%
CRY BuyCryoLife Inc$4,697,000
+12.0%
471,603
+24.8%
3.35%
-19.7%
ICCC BuyImmuCell Corp$389,000
+31.0%
80,946
+16.3%
0.28%
-6.1%
CEMI  Chembio Diagnostics Inc$288,000
+2.5%
83,3720.0%0.20%
-26.8%
SCLN ExitSciclone Pharmaceuticals Inc$0-135,000
-100.0%
-0.68%
CUTR ExitCutera Inc$0-86,168
-100.0%
-0.87%
BCR ExitBard C R Inc$0-22,000
-100.0%
-2.93%
MCK ExitMcKesson Corp$0-42,100
-100.0%
-6.76%
MYGN ExitMyriad Genetics Inc$0-378,200
-100.0%
-7.89%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-04-23
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARLES RIV LABS INTL INC17Q4 201712.8%
GILEAD SCIENCES INC16Q4 202214.5%
CARDINAL HEALTH INC15Q4 202214.8%
IMMUCELL CORP15Q2 20171.7%
MCKESSON CORP14Q3 202214.6%
ANTHEM INC12Q4 201714.3%
TRIPLE-S MGMT CORP12Q4 20168.7%
LIFEPOINT HOSPITALS INC11Q2 201613.3%
SUPERNUS PHARMACEUTICALS INC10Q3 202115.5%
ANIKA THERAPEUTICS INC10Q4 201713.0%

View HealthInvest Partners AB's complete holdings history.

Latest significant ownerships (13-D/G)
HealthInvest Partners AB Q1 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVAMED INCMarch 03, 2011405,8755.1%
THERAGENICS CORPFebruary 11, 20093,322,8469.9%
BIO IMAGING TECHNOLOGIES INCJanuary 09, 2009766,4255.3%
ALLION HEALTHCARE INCJuly 07, 2008887,2554.6%
SONIC INNOVATIONS INCJune 26, 20081,328,2014.9%
CANDELA CORP /DE/June 06, 2008697,1643.1%
INTEGRAMED AMERICA INCJune 02, 20082,2000.0%
AFP IMAGING CORPFebruary 04, 200827,5200.2%
OPHTHALMIC IMAGING SYSTEMSDecember 28, 2007834,4404.9%
ANGEION CORP/MNOctober 16, 2007196,0244.8%

View HealthInvest Partners AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-30
13F-HR2023-02-14
13F-HR2022-10-21
13F-HR2022-07-08
13F-HR2022-05-05
13F-HR2022-01-18
13F-HR2021-11-08
13F-HR2021-08-10
13F-HR2021-04-30

View HealthInvest Partners AB's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (140320000.0 != 140321000.0)

Export HealthInvest Partners AB's holdings